The objective of this study was to carry out a multi-country concurrent accuracy evaluation of the ADVIA Centaur® Syphilis CLIA assay (Siemens Healthcare) compared to the reference TPPA (SERODIA-TP·PA®; Fujirebio Diagnostics) for syphilis screening (serum samples) amongst a sample of MSM attending the Infectious Disease Department in Verona (Italy), the GenitoUrinary (GU)-clinic in the Mater Dei Hospital, L-Imsida (Malta) and the Brighton & Hove Sexual Health and Contraception Service (SHAC) in Brighton (UK). Using the same protocol and criteria, an additional sample of patients (MSM) was enrolled at the Verona site in the framework of an EU-funded project called Sialon [11 (link)].
Free full text: Click here